| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K84807411 |
| PharmacoGx | BRD-K84807411 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IFNE | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | POLDIP3 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | HDAC11 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |
| mRNA | KEL | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | UBAP1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | PDP1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | EIF5A | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | WFDC13 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | CCL21 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | RIF1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
